Latest Hikma News & Updates

See the latest news and media coverage for Hikma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Hikma

Global pharmaceutical company

Latest news about Hikma

May 1 Hikma

Hikma's legal team argues before US Supreme Court

They advocate for skinny labels to ensure uninterrupted access to safe, affordable generic medicines for American patients.
April 28 Hikma

Hikma announces settlement for VYNDAMAX generic

Hikma settles with Pfizer, allowing market entry on 1 June 2031, ahead of 2035 patent expiry. This supports first-to-file strategy for affordable access.
April 23 Hikma

Hikma updates trading and reiterates guidance

CEO Darwazah highlights strong business performance, new product launches, and a device partnership for inhalation platform. Group expects revenue and profit growth.
April 23 Hikma

Hikma reiterates full-year 2026 guidance

The Group reports an encouraging start, maintains 2026 revenue and operating profit guidance, announces a final dividend and a $250 million share buyback programme.

April 30 Yahoo Finance

Pfizer (PFE) Reaches Settlement to Extend VYNDAMAX Patent Protection Until 2031

Pfizer Inc. (NYSE:PFE) is one of the most active US stocks to buy right now. On April 28, Pfizer...
April 29 SCOTUSblog

Justices poised to protect generics manufacturers from liability for decisions of pharmacists about prescribing their products

Ronald Mann, Justices poised to protect generics manufacturers from liability for decisions of pharmacists about prescribing their products, SCOTUSblog (Apr.
April 28 STAT News

Pharmalittle: We're reading about a Supreme Court hearing on 'skinny labels,' AstraZeneca U.K. expansion, and more

AstraZeneca will resume expansion of its U.K. R&D operations after the trade deal with the U.S. included measures to lift U.K. drug spending...
April 28 The Globe and Mail

Hikma Advances $250m Buyback, Shrinks Share Count Further

Detailed price information for Hikma Pharmaceuticals Plc (HKMPF) from The Globe and Mail including charting and trades.

Never miss news about Hikma

Track Hikma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Discover what's making headlines across other trending companies.